The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo, now the country’s largest on record with over 7,000 confirmed cases and spread across seven provinces, anchors trader sentiment for 2026 markets. Recent confirmation of a case in the northwestern Sud-Ubangi province signals accelerating geographic momentum amid insecurity and population movement, while an imported case in France and Uganda’s contained cluster (declared over in August) highlight cross-border risks. WHO’s public health emergency designation and assessments of high regional threat to neighbors like Central African Republic and South Sudan underscore the primary catalysts. With vaccination campaigns limited by supply and the year’s final quarter approaching, traders monitor new detections, contact-tracing gaps, and any further international imports as key swing factors.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$38,589 ปริมาณ
Dec 31, 2026
South Sudan
68%
Rwanda
22%
Burundi
52%
United States
19%
Canada
23%
Kenya
24%
India
46%
Republic of the Congo
20%
Nigeria
51%
Ethiopia
52%
Somalia
36%
China
14%
$38,589 ปริมาณ
South Sudan
$4,293 ปริมาณ
68%
Rwanda
$2,149 ปริมาณ
22%
Burundi
$202 ปริมาณ
52%
United States
$10,507 ปริมาณ
19%
Canada
$2,307 ปริมาณ
23%
Kenya
$235 ปริมาณ
24%
India
$737 ปริมาณ
46%
Republic of the Congo
$12,400 ปริมาณ
20%
Nigeria
$25 ปริมาณ
51%
Ethiopia
$107 ปริมาณ
52%
Somalia
$129 ปริมาณ
36%
China
$3,543 ปริมาณ
14%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo, now the country’s largest on record with over 7,000 confirmed cases and spread across seven provinces, anchors trader sentiment for 2026 markets. Recent confirmation of a case in the northwestern Sud-Ubangi province signals accelerating geographic momentum amid insecurity and population movement, while an imported case in France and Uganda’s contained cluster (declared over in August) highlight cross-border risks. WHO’s public health emergency designation and assessments of high regional threat to neighbors like Central African Republic and South Sudan underscore the primary catalysts. With vaccination campaigns limited by supply and the year’s final quarter approaching, traders monitor new detections, contact-tracing gaps, and any further international imports as key swing factors.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
ตลาดเปิดเมื่อ: May 22, 2026, 12:35 PM ET
ปริมาณการซื้อขาย
$38,589วันสิ้นสุด
Jan 1, 2027ตลาดเปิดเมื่อ
May 22, 2026, 12:35 PM ETผู้ตัดสินผล
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo, now the country’s largest on record with over 7,000 confirmed cases and spread across seven provinces, anchors trader sentiment for 2026 markets. Recent confirmation of a case in the northwestern Sud-Ubangi province signals accelerating geographic momentum amid insecurity and population movement, while an imported case in France and Uganda’s contained cluster (declared over in August) highlight cross-border risks. WHO’s public health emergency designation and assessments of high regional threat to neighbors like Central African Republic and South Sudan underscore the primary catalysts. With vaccination campaigns limited by supply and the year’s final quarter approaching, traders monitor new detections, contact-tracing gaps, and any further international imports as key swing factors.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
ปริมาณการซื้อขาย
$38,589วันสิ้นสุด
Jan 1, 2027ตลาดเปิดเมื่อ
May 22, 2026, 12:35 PM ETผู้ตัดสินผล
0x65070BE91...The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo, now the country’s largest on record with over 7,000 confirmed cases and spread across seven provinces, anchors trader sentiment for 2026 markets. Recent confirmation of a case in the northwestern Sud-Ubangi province signals accelerating geographic momentum amid insecurity and population movement, while an imported case in France and Uganda’s contained cluster (declared over in August) highlight cross-border risks. WHO’s public health emergency designation and assessments of high regional threat to neighbors like Central African Republic and South Sudan underscore the primary catalysts. With vaccination campaigns limited by supply and the year’s final quarter approaching, traders monitor new detections, contact-tracing gaps, and any further international imports as key swing factors.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย